JPMorgan Chase & Co’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $44.6K | Sell |
|
|||||
|
2024
Q4 | $143K | Buy |
|
|||||
|
2024
Q3 | $65.9K | Buy |
|
|||||
|
2024
Q2 | $61.1K | Buy |
|
|||||
|
2024
Q1 | $537 | Sell |
|
|||||
|
2023
Q4 | $305 | Hold |
|
|||||
|
2023
Q3 | $608 | Sell |
|
|||||
|
2023
Q2 | $2.9K | Sell |
|
|||||
|
2023
Q1 | $868K | Hold |
|
|||||
|
2022
Q4 | $701K | Sell |
|
|||||
|
2022
Q3 | $1.15M | Sell |
|
|||||
|
2022
Q2 | $1.96M | Sell |
|
|||||
|
2022
Q1 | $2.21M | Sell |
|
|||||
|
2021
Q4 | $3.63M | Sell |
|
|||||
|
2021
Q3 | $4.92M | Sell |
|
|||||
|
2021
Q2 | $8.19M | Buy |
|
|||||
|
2021
Q1 | $19.5M | Buy |
|
|||||
|
2020
Q4 | $6.16M | Buy |
|
|||||
|
2020
Q3 | $3.96M | Buy |
|
|||||
|
2020
Q2 | $6.14M | Buy |
|
|||||
|
2020
Q1 | $2.09M | Sell |
|
|||||
|
2019
Q4 | $8.45M | Sell |
|
|||||
|
2019
Q3 | $5.42M | Sell |
|
|||||
|
2019
Q2 | $29.1M | Sell |
|
|||||
|
2019
Q1 | $17.3M | Buy |
|
|||||
|
2018
Q4 | $9.22M | Buy |
|
|||||
|
2018
Q3 | $16.7M | Buy |
|
|||||
|
2018
Q2 | $13.5M | Buy |
|
|||||
|
2018
Q1 | $11.6M | Buy |
|
|||||
|
2017
Q4 | $464K | Buy |
|
|||||
|
2017
Q3 | $355K | Buy |
|
|||||
|
2017
Q2 | $182K | Sell |
|
|||||
|
2017
Q1 | $258K | Sell |
|
|||||
|
2016
Q4 | $317K | Buy |
|
|||||
|
2016
Q3 | $196K | Buy |
|
|||||
|
2016
Q2 | $102K | Sell |
|
|||||
|
2016
Q1 | $421K | Sell |
|
|||||
|
2015
Q4 | $816K | Sell |
|
|||||
|
2015
Q3 | $711K | Sell |
|
|||||
|
2015
Q2 | $10.4M | Sell |
|
|||||
|
2015
Q1 | $26.9M | Sell |
|
|||||
|
2014
Q4 | $39.2M | Buy |
|
|||||
|
2014
Q3 | $15.3M | Buy |
|